Skip to main content Skip to footer menu

Clifford Chance

Tagged: 'European Union (EU)'

Results 1-10 of 476

Healthcare & Life Sciences Update: The Netherlands - November 2014

11 November 2014


The regulatory environment for companies active in the Dutch healthcare and life sciences sector continues to change. Rules regarding advertising have been amended and new supervision instruments are being introduced. On a European level, pharmacovigilance has...

EMIR: CCPs and Trade Repositories

7 November 2014


The market infrastructure to support EU derivatives reforms is quickly taking shape. This year has seen the first authorisations of EU central counterparties (CCPs), triggering the first clearing obligation procedure under the EU regulation on OTC derivatives,...

LCR and Securitisation – 2B or not 2B

6 November 2014


The European Commission has now published the final draft of the Commission Delegated Regulation with regard to liquidity coverage requirement (the "LCR Delegated Act"), likely to apply to EU banks from late 2015. Once approved, the LCR Delegated Act...

EMIR: Clearing Exemption for Pension Scheme Contracts

4 November 2014


Pension schemes are important counterparties for firms active in the EU OTC derivatives market and the EU regulation on OTC derivatives, central counterparties and trade repositories (EMIR) provides a temporary exemption from the clearing obligation for certain...